LAVENGEL

Serial Number 88427217
Registration 6234553
700

Registration Progress

Application Filed
May 13, 2019
Under Examination
Nov 26, 2019
Approved for Publication
Oct 1, 2019
Published for Opposition
Oct 1, 2019
Registered
Dec 29, 2020

Trademark Image

LAVENGEL

Basic Information

Serial Number
88427217
Registration Number
6234553
Filing Date
May 13, 2019
Registration Date
December 29, 2020
Published for Opposition
October 1, 2019
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 29, 2020
Registration
Registered
Classes
005

Rights Holder

AOX BIOPHARMA LLC

16
Address
1720 WALLACE AVENUE
SUITE B
ST. CHARLES, IL 60174

Ownership History

RTD Neutraceuticals, LLC

Original Applicant
16
Johnson City, TN

RTD Neutraceuticals, LLC

Owner at Publication
16
Johnson City, TN

RTD Neutraceuticals, LLC

Original Registrant
16
Johnson City, TN

AOX BIOPHARMA LLC

New Owner After Registration #1
16
ST. CHARLES, IL

Legal Representation

Attorney
April L. Besl

USPTO Deadlines

Next Deadline
512 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-12-29)
Due Date
December 29, 2026
Grace Period Ends
June 29, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

28 events
Date Code Type Description Documents
Feb 15, 2023 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Dec 29, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 24, 2020 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Nov 21, 2020 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Nov 12, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 12, 2020 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Oct 29, 2020 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Oct 29, 2020 IUAF S USE AMENDMENT FILED Loading...
May 22, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 20, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 20, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
May 20, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 26, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 1, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 1, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 11, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 29, 2019 ALIE A ASSIGNED TO LIE Loading...
Aug 13, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 13, 2019 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Aug 13, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Aug 13, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Aug 13, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 9, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 9, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 9, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 29, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
May 29, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 16, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical skincare products for animals used for healing skin disruptions, particularly, lick granulomas, mange, insect bites, dermatitis, abrasions, itchy skin, wounds, burns, surgical incision, shingles lesions, cold sores, methicillin resistant staphylococcus aureus (MRSA) and methicillin resistant staphylococcus pseudintermedius (MRSP)
First Use Anywhere: May 27, 2020
First Use in Commerce: May 27, 2020

Classification

International Classes
005